Parkinsonism and dopa.
D004295:Dihydroxyphenylalanine / Q000378:metabolism / Q000627:therapeutic use*; D006801:Humans; D009520:New Zealand; D009966:Orphenadrine / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy* / Q000453:epidemiology; D010301:Parkinson Disease, Postencephalitic / Q000188:drug therapy; D014282:Trihexyphenidyl / Q000627:therapeutic use
D004295:Dihydroxyphenylalanine; D014282:Trihexyphenidyl; D009966:Orphenadrine